Occlutech International AB
Location
Skåne
Founded
2007-01-23
Website
Risk Signals
43 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Commercial Equipment, Not Elsewhere Classified), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about Occlutech International AB
Live alerts from global media, monitored by Business Radar
2025-05-20 (africa-press.net)
King Faisal Hospital performs 's first stroke-related heart surgery -
King Faisal Hospital has successfully carried out Rwanda's first percutaneous closure of a patent foramen ovale (PFO), a ...
Read more
2025-04-08 (knockinglive.com)
Devices for closing the left atrium ears Rynek 2025 SE Analysis -
"Devices for closing the left vestibule of the vestibule Surel of the market:
Read more
2025-03-15 (sante.fr)
Intra-Cardiac occlusion DM-Flex-Pusher II (51FP100) distribution cable in combination with the ODSIII 6F (98DS006 & 98us006) and ODSV1 6F (51us006)-Occlutech distribution system-
Intra-Cardiac occlusion DM-Flex-Pusher II (51FP100) distribution cable in combination with the ODSIII 6F (98DS006 & 98US006) and ODSV1 6F (51US006)-Occlutech distribution system on the site of the National Agency for the Safety of Medication of Health Products
Read more
2025-03-03 (igj.nl)
OCCLUTECH AB International, FSCA-2025-001, Packs Contouing Flex-Pusher II | Warning Healthcare and Youth Inspectorate
OCCLUTech has established that certain process packages with Flex-Pusher II (51FP100) to which this corrective measure applies, have a size recommendation of 6F for ODSIII and ODSV1 on the label of the procedure package and the sterile bag that the implant could lead to incompatibility.
Read more
2024-12-23 (igj.nl)
Occlutech GmbH, FSCA-2024-002, Figulla Flex II ASD Occluder | Warning | Healthcare and Youth Inspectorate
Occlutech has identified that products affected by this corrective action have a size recommendation of ODS III (REF 98DS006) on the label of the Procedure Pack box and the sterile pouch of the implant that might lead to incompatibility. The recommendation and labelling of the Occlutech Delivery Set with REF 51DS007 as 7F on the affected Procedure Pack box and the sterile pouch of the affected implant remains correct as per specification. It was identified that there were some discrepancies between the labelled size for ODS III and the results from internal tests. The size of compatible delivery system on the labels is too small. Instead of the labelled 6F ODS III size, a minimum size of 7F ODS III should be used. The usage of an undersized delivery system for the implantation of the Figulla Flex II ASD could result in damage to the Occluder device.
Read more
2024-08-28 (pr-inside.com)
Occlutech(R) Announces Commercial Cases of Occlutech ASD Occluder Device ...
Occlutech(R) Announces Commercial Cases of Occlutech ASD Occluder Device ...
Read more
2024-06-12 (ihk.de)
“I can’t work like this” – DIHK campaign shows problems in the economy
June 11, 2024: Too often in the past, announcements of relief have not been followed by concrete implementation steps. Quite the opposite: companies are being overwhelmed by more and more restrictions, restrictions and regulations.
Read more
2024-01-15 (cardiacrhythmnews.com)
Occlutech to launch atrial septal defect occluder in the USA - Cardiac Rhythm News
Occlutech has announced that the US Food and Drug Administration (FDA) has approved the Occlutech ASD Occluder and Occlutech Pistol Pusher for the treatment of atrial septal defects (ASD). With this approval, Occlutech will immediately begin commercialisation in an exclusive partnership with
Read more
2024-01-08 (yahoo.com)
Occlutech(R) Announces FDA Approval of its Occlutech(R) ASD Occluder and Occlutech(R) Pistol Pusher, a Minimally Invasive Cardiac Device and Delivery System to Treat Atrial Septal Defects
SCHAFFHAUSEN, CH / ACCESSWIRE / January 8, 2024 / Occlutech Holding AG Occlutech ASD Occluder delivers positive procedural outcomes with strong efficacy and a low rate of complications[i] Occlutech®, a world leading specialist provider of minimally ...
Read more
2023-03-20 (tctmd.com)
The Occlutech AFR: Matching Shunt Length and Diameter to the Patient
Slide Presentation: The Occlutech AFR: Matching Shunt Length and Diameter to the Patient
Read more
2023-03-14 (medicaldevice-network.com)
Occlutech begins subject enrolment in Atrial Flow Regulator trial
Minimally invasive cardiac devices provider Occlutech has enrolled the first participant in the FROST-HF study of its Atrial Flow Regulator.
Read more
2022-01-14 (bakermckenzie.com)
Baker McKenzie advised Occlutech Holding AG on its SEK 450 million private placement of Swedish Depositary Receipts (SDRs) | Newsroom | Baker McKenzie
The purpose of the issue is to support Occlutech's significant opportunities in the US market, continue to facilitate Occlutech's growth and ...
Read more